Alla studier
RekryteringTerapeutisk bekräftande (Fas III)Interventionell

ANA4CKD - Randomized multicenter double-blind controlled trial comparing anakinra to prednisone for gout flare in patients with chronic kidney disease stage 4-5 or kidney transplantation

This study, called ANA4CKD, is comparing two medicines, anakinra and prednisone, to see which is better at treating sudden, painful gout attacks. It focuses on people who have advanced kidney disease, are on dialysis, or have had a kidney transplant. Both men and women over 18 can take part. Some participants will receive anakinra, some will receive prednisone, and others will get a dummy treatment (placebo). The main aim is to check if anakinra helps reduce pain more effectively within three days compared to prednisone. Researchers will also look at how quickly people get better, how long they need treatment, and if there are any side effects, including serious ones like infections or heart problems.

Överblick

Status
Rekrytering
Fas
Terapeutisk bekräftande (Fas III)
Sponsor
Assistance Publique Hopitaux De Paris
Inskrivningsmål
234
Starta
21 okt 2024

Vad handlar denna studie om?

This research study, known as ANA4CKD, is designed to find the best way to treat painful gout flares for people who are also dealing with serious kidney problems or have had a kidney transplant. Gout is a type of arthritis that causes sudden, severe joint pain. When you have kidney issues, treating gout can be tricky because some common medications might not be safe. This study is comparing two specific treatments: anakinra and prednisone. Both are known to help with inflammation, but researchers want to see which one is more effective and safer for this particular group of patients.

The main goal is to compare how well these two medications reduce pain during a gout attack. Participants will be closely monitored, and their pain levels will be checked regularly, especially within the first few days of treatment. Researchers will also look at how quickly symptoms improve, how long the treatment is needed, and whether patients experience any side effects. These side effects could range from minor reactions at the injection site to more serious health concerns like infections or heart issues.

By carefully studying these two treatments, the research team hopes to provide doctors with clearer guidelines on how to best help patients who suffer from gout flares alongside kidney disease. This could lead to more effective and safer treatment options, improving the quality of life for many people in a similar situation.

Viktiga punkter

  • This study compares two treatments for gout flares in people with kidney disease or kidney transplants.
  • It aims to find out which treatment is safer and more effective at reducing pain.
  • Participants will receive either anakinra, prednisone, or a placebo.
  • The main focus is on pain reduction within the first few days and monitoring for side effects.
  • The study lasts for one month, with close medical supervision.
  • You won't know which treatment you are receiving until the study is over.

Vem kan vara berättigad?

You might be able to join this study if you are 18 years old or older and are currently experiencing a painful gout attack that has not yet been treated. It's really important that you have certain kidney conditions.

Specifically, you need to have advanced kidney disease (called stage 3b, 4, or 5), be receiving dialysis, or have had a kidney transplant. Both men and women can take part in this research.

Your doctor will check your medical history and current health to make sure you fit all the requirements for this study.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Är du 18 år eller äldre?
  2. Are you currently having a gout attack that hasn't been treated yet?
  3. Do you have advanced kidney disease (stage 3b, 4, or 5), are you on dialysis, or have you had a kidney transplant?
  4. Are you able to commit to the study visits and follow-up for about one month?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to participate, you will receive either one of the study medications (anakinra or prednisone) or a placebo (a dummy treatment that looks like the real medicine but contains no active drug). You won't know which one you're getting, nor will your doctors, until after the study is complete. You will have regular check-ups, and your pain levels will be recorded, mainly over the first three to five days. We'll also be monitoring how quickly your gout improves and if you experience any side effects. This includes looking at things like injection site reactions, any changes in your blood tests (like certain cells), or more serious health issues. We'll also track any hospital stays, use of pain relief, and how long you might be off work. The study will continue to monitor you for one month.

Potentiella risker och fördelar

Taking part in this study might offer the benefit of receiving a potential treatment for your gout flare and a high level of medical care and monitoring. However, as with any medical treatment, there are potential risks, including side effects from the medications or placebo. These could include reactions where the injection is given, changes in blood tests (like a drop in certain white blood cells), or more serious events like infections or heart problems. It's important to remember that you can stop participating in the study at any time, for any reason, without it affecting your usual medical care.

Platser (1)

Vissa platsangivelser är ungefärliga. Vi arbetar på att förbättra detta — vänligen kontrollera med testteamet innan du reser.
  • —
    Obekräftad
    Frankrike

Vanliga frågor

What is gout?

Gout is a type of arthritis that causes sudden, very painful swelling and redness in joints, usually in the big toe.

Why are kidney problems important in this study?

Many gout medications can have side effects on the kidneys, so this study is looking for safer and more effective treatments for people who already have kidney disease or a transplant.

Vad är en 'placebo'?

A placebo is a dummy treatment, like a sugar pill or a saline injection. It looks exactly like the real medicine but doesn't contain any active drug. It helps researchers compare if the actual drug is better than no treatment.

Kommer jag att veta vilken behandling jag får?

No, this is a 'blinded' study, meaning neither you nor your doctors will know if you're receiving anakinra, prednisone, or the placebo. This helps make the study results fair.

Hur länge kommer jag att vara involverad i studien?

While the main pain evaluation is in the first few days, your health will be monitored for about one month after starting treatment in the study.

Hur du får reda på mer

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "ANA4CKD - Randomized multicenter double-blind controlled tri…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.